HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • Corona Virus
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
    • Holiday 2020
  • Contact Us

What Medicaid’s Hepatitis C Crisis Means for Medicare Part D

8/16/2016

0 Comments

 
Melissa Fausz   |   August 11, 2016 
Three million Americans suffer from Hepatitis C. The liver disease killed nearly 20,000 Americans in 2014 – officially claiming more American lives than any other infectious disease. One may wonder why this condition destroys so many lives, given that Hepatitis C is a curable illness.
Part of the answer comes down to the type of health care many Hepatitis C sufferers receive. Of the 3 million Americans affected by this disease, a full third of them are Medicaid eligible. Medicaid recipients frequently face major difficulties in accessing primary care and health care screenings, which are essential to detecting Hepatitis C (it can often be asymptomatic) and treating the patient before major liver damage has been done.
The other key obstacle facing Medicaid recipients currently struggling with Hepatitis C is access to effective treatment once a diagnosis has been received. Recently, the National Association of Medicaid Directors (NAMD), an association which represents state directors of Medicaid programs across the country, called on Congress to address the strain that the cost of Hepatitis C treatment is placing on the nation’s largest health insurer.
Among the many difficulties specifically expressed, NAMD points out that the current rebate system used to set drug prices in the Medicaid program makes it difficult, if not impossible, to negotiate lower rates for Hepatitis C medications while maintaining a steady supply to meet patient needs. This is because the existing rebate program sets very strict and inflexible guidelines for the pricing of prescription medications under Medicaid.
As a possible solution, NAMD suggests that this program could be changed to “enable states to effectively utilize market forces to [reduce treatment costs] on their own.” If this suggestion sounds familiar to some, it could be due to the fact that similar negotiating power was one of the selling points for another government-run health care program: Medicare Part D.
Part D, a Medicare prescription drug program, went into effect in 2006. The goal of the program was to increase seniors’ access to a wider variety of prescription medications, while utilizing the market forces of competition to control the costs of the program. The program works by allowing administrators to negotiate prices directly with drug companies, rather than relying on a strict rebate formula like Medicaid.
The program is far from perfect, but it deserves credit for costing 45 percent less than projected, resulting in the federal government spending $349 billion less than originally anticipated.

To Continue reading:https://morningconsult.com/opinions/medicaids-hepatitis-c-crisis-means-medicare-part-d/

​Melissa Fausz is a Senior Policy Analyst at Americans for Prosperity.

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy